HighTide Therapeutics 관리
관리 기준 확인 1/4
HighTide Therapeutics' CEO is Liping Liu, appointed in Feb 2018, has a tenure of 6.75 years. total yearly compensation is CN¥14.66M, comprised of 24.1% salary and 75.9% bonuses, including company stock and options. directly owns 0.96% of the company’s shares, worth HK$6.00M. The average tenure of the management team and the board of directors is 2.8 years and 1.8 years respectively.
주요 정보
Liping Liu
최고 경영자
CN¥14.7m
총 보상
| CEO 급여 비율 | 24.1% |
| CEO 임기 | 6.8yrs |
| CEO 소유권 | 1.0% |
| 경영진 평균 재임 기간 | 2.8yrs |
| 이사회 평균 재임 기간 | 1.8yrs |
CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥601m |
| Mar 31 2024 | n/a | n/a | -CN¥770m |
| Dec 31 2023 | CN¥15m | CN¥4m | -CN¥939m |
| Sep 30 2023 | n/a | n/a | -CN¥803m |
| Jun 30 2023 | n/a | n/a | -CN¥666m |
| Mar 31 2023 | n/a | n/a | -CN¥428m |
| Dec 31 2022 | CN¥7m | CN¥4m | -CN¥190m |
| Dec 31 2021 | CN¥7m | CN¥3m | -CN¥221m |
보상 대 시장: Liping's total compensation ($USD2.07M) is above average for companies of similar size in the Hong Kong market ($USD234.60K).
보상과 수익: Liping's compensation has increased whilst the company is unprofitable.
CEO
Liping Liu (54 yo)
6.8yrs
테뉴어
CN¥14,663,000
보상
Dr. Liping Liu has been the Chief Executive Officer and Executive Director of HighTide Therapeutics, Inc. since February 28, 2018 and its chairwoman since December 22, 2023 She has been the Chief Executive...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairwoman | 6.8yrs | CN¥14.66m | 0.96% HK$ 6.0m | |
| Deputy GM & Executive Director | 7.4yrs | CN¥10.83m | 0.34% HK$ 2.1m | |
| Chief Financial Officer | 1.9yrs | 데이터 없음 | 데이터 없음 | |
| Chief Development Officer | 3.8yrs | 데이터 없음 | 데이터 없음 | |
| VP & Joint Company Secretary | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| Joint Company Secretary | less than a year | 데이터 없음 | 데이터 없음 |
2.8yrs
평균 재임 기간
50.5yo
평균 연령
경험이 풍부한 관리: 2511's management team is considered experienced (2.8 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairwoman | 6.8yrs | CN¥14.66m | 0.96% HK$ 6.0m | |
| Deputy GM & Executive Director | 1.5yrs | CN¥10.83m | 0.34% HK$ 2.1m | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | less than a year | CN¥4.00k | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director | 4yrs | CN¥1.84m | 0.17% HK$ 1.0m | |
| Independent Non-Executive Director | less than a year | CN¥4.00k | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director | 2yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director | 3yrs | CN¥8.90m | 0.19% HK$ 1.2m | |
| Independent Non-Executive Director | less than a year | CN¥4.00k | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
1.8yrs
평균 재임 기간
54yo
평균 연령
경험이 풍부한 이사회: 2511's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.